Compare HCA Health Inc (HCA) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs PepsiCo, Inc. — how do they compare? HCA Health Inc trades at $371.74 (market cap $82.17B), while PepsiCo, Inc. trades at $134.72 (market cap $184.89B). The key difference: PepsiCo, Inc. is far larger — about 2.3× HCA Health Inc's market cap, and PepsiCo, Inc. pays the higher dividend (4.37%). Which is the better fit depends on your goals.
| HCA | PEP | |
|---|---|---|
Market Cap | $82.17B | $184.89B |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $170.44 |
52-Week Low | $334.32 | $135.40 |
Enterprise Value | $131.08B | $227.39B |
Dividend Yield | 0.84% | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
PepsiCo (PEP) trades at $134.61, down 1.83% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $93.93B in 2025, with net income of $8.24B and a net margin of 10.78%. Recent quarterly earnings have consistently beaten expectations, and the stock offers a dividend yield near 4% with upcoming payments. Analysts maintain a consensus price target of $158.50, suggesting upside potential despite mixed sentiment.
PEP presents a balanced outlook with strong profitability and dividend stability, but faces risks from pricing pressures and volatile cash flows. The current valuation at a P/E of 17.75 is reasonable relative to historical norms, while institutional activity shows mixed positioning. Investors should weigh solid fundamentals against near-term headwinds in consumer spending and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
